Announcements Trials
Browse Landscape

Phase

Phase NA 66Phase 2 47Phase 3 17Phase 1 17Phase EARLY_PHASE1 2Phase 4 2Phase 2/3 2Phase 1/2 1

Status

Suspended 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 117Triple Negative Breast Neoplasms 9Neoplasms 4Neoplasm Metastasis 4Lung Neoplasms 4HER2-positive Breast Cancer 4Prostatic Neoplasms 3Motor Activity 3Melanoma 3Inflammatory Breast Neoplasms 3Head and Neck Neoplasms 3Depression 3Colorectal Neoplasms 3Sarcoma 2Peripheral Nervous System Diseases 2Ovarian Neoplasms 2Fatigue 2Carcinoma, Ductal, Breast 2Breast Diseases 2Breast Carcinoma In Situ 2Anxiety Disorders 2Uterine Cervical Neoplasms 1Urogenital Neoplasms 1Urinary Incontinence 1To Evaluate the Effectiveness of GM1 in the Prevention of Albumin-paclitaxel Therapy Induced Peripheral Neuropathy in Breast Cancer Patients 1Smoking 1Sleepiness 1Seroma 1Recurrence 1Radiodermatitis 1

Interventions

dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Taxes 1Ranitidine 1Paclitaxel 1Famotidine 1Diphenhydramine 1Dexamethasone 1Cimetidine 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Breast Carcinoma In Situ × Breast × Clear all
NCT03077841 2026-03-05

Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer

M.D. Anderson Cancer Center

Phase 2/3 Suspended
928 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT04862585 2025-08-20

Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel

Ohio State University Comprehensive Cancer Center

Phase 2/3 Completed
130 enrolled 8 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡